Mahendran Balachandran

Based in
Bangalore, India
Specializing In
No items found.

Mahendran Balachandran joined Accel in 2008.

Mahendran has been venture investing since 2005 bringing with him two decades of business leadership in technology companies, including Apple and Tektronix.

As a partner at Accel, he is responsible for investments in Bayestree, Indifi, Finbots, Probe, Power2SME, Sayre, Samunnati, USPL, Vinculum, and Zumutor.

Mahendran holds a management degree from IIM Bangalore and a B.Tech degree from NITW.

Focus

Consumer

Media

Cloud/SaaS

Relationships

Bayestree
Series A
2019

Avijit Biswas

Partha Pratim Ghosh

Girish Koppa

AI/ML platform for workflow automation

Brick&Bolt
Series A
2022

Jayesh Rajpurohit

Arpit Rajpurohit

Tech-enabled real estate platform

Finbots.AI
Series A
2022

Sanjay Uppal

Shripad Keni

AI-enabled banking platform

Fundly.ai
Seed
2023

Amit Chawla

Shreeram Ramanathan

Financing platform

Gut Wellness Club
Seed
2023

Anita Shet

AI-based healthcare platform to heal naturally

Indifi
Seed / Series A
2015

Alok Mittal

Siddharth Mahanot

SME lending market place

Mynvax
Series A
2021

Gautam Nadig

Raghavan Varadarajan

Vaccines against respiratory diseases

Power2SME
Series A
2013

R. Narayan

Debabrata Majumdar

Snehashish Bhattacharjee

B2B marketplace for SMEs

Probe Information
Series A
2010

W S Ravishankar

Atul Shinghal

Information services with a specialization in financial data

Samunnati
Series B
2017

Anil Kumar

Microfinance solutions for agricultural enterprises

Sayre Therapeutics
Series A
2015

Shukrit Sudhir Chimote

End-to-end oncology & immunology solutions

Taascom
Series A
2019

Ranga Raj

Business model strategy transformation for the service-based economy

USPL Wrogn
Series A
2012

Anjana Reddy

Marketplace for celebrity endorsed apparel and accessories

Vinculum
Series A
2010

Venkataramana Nott

Annajee Nott

Deepak Singla

Piyush Madan

Omnichannel retailing for SaaS-based products

Zumutor
Seed
2015

Kavitha Iyer Rodrigue

Immuno-Oncology company developing biosimilars and biobetters

See More
No items found.

Noteworthy

Test Collection Entry 1
Uh oh

Oh no!

Looks like your firewall is blocking some of our new website's features. We’re working on a fix so that you’ll have the same great experience as others. Please contact us if you have questions.